Results 11 to 20 of about 46,054 (219)
In stent restenosis: bane of the stent era [PDF]
Journal of Clinical Pathology, 2006 The long term outcome of stent implantation is affected by a process called in stent restenosis (ISR). Multiple contributory factors have been identified, but clear understanding of the overall underlying mechanism remains an enigma. ISR progresses through several different phases and involves numerous cellular and molecular constituents. Platelets and
Amit K. Mitra, Devendra K. Agrawal
openaire +2 more sources
Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. [PDF]
, 2009 Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents. A variety of antibodies and transgenic and knockout strains are available
Deuse, Tobias +3 more
core +2 more sources
Robust optimization of cardiovascular stents: A comparison of methods [PDF]
, 2004 This is the post-print version of the Article. The official published version can be accssed from the links below. Copyright @ 2004 Taylor & FrancisModern engineering design contains both creative and analytic components.
Atherton, MA, Bates, RA
core +1 more source
Stent implant follow-up in intravascular optical coherence tomography images [PDF]
, 2009 The objectives of this article are (i) to utilize computer methods in detection of stent struts imaged in vivo by optical coherence tomography (OCT) during percutaneous coronary interventions (PCI); (ii) to provide measurements for the assessment ...
Carlier, Stephane Guy +4 more
core +2 more sources
Restenosis begets restenosis: implications for stent selection [PDF]
Netherlands Heart Journal, 2008 Identifying the risk for restenosis is of critical importance in the stent selection process of patients undergoing percutaneous coronary intervention (PCI). Therefore, we sought to determine if a history of clinical recurrence (CR) after PCI increases the risk of CR after treatment of a de novo lesion in another coronary artery.We retrospectively ...
Jasper S. Wijpkema +5 more
openaire +4 more sources
Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]
, 2012 Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A +7 more
core +2 more sources
Future of smart cardiovascular implants [PDF]
, 2018 Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav +2 more
core +1 more source
Emotions and scope effects in the monetary valuation of health [PDF]
, 2018 JEL classifications: H41 H51 I11 I18 I31This study presents evidence on the role of emotions in the monetary evaluation of health technologies, namely, drug-eluting stents (DES) in our case.
Araña, Jorge +3 more
core +1 more source
Current Management of In-Stent Restenosis [PDF]
Korean Circulation Journal, 2018 Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons.
Ae-Young Her, Eun-Seok Shin
openaire +3 more sources
Prevention of coronary restenosis by stenting [PDF]
European Heart Journal, 1988 Balloon angioplasty fails to provide acceptable long-term results for a significant proportion of patients. An intravascular mechanical support, developed with the aim of preventing restenosis and acute closure of diseased arteries after transluminal angioplasty, was implanted in 44 patients (39 male and five female), aged from 35 to 70 years (mean 56 ...
Sigwart, U. +9 more
openaire +5 more sources